- Home
- ABOS
as 10-28-2025 9:36am EST
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | NEWTON |
| Market Cap: | 113.9M | IPO Year: | 2021 |
| Target Price: | $8.00 | AVG Volume (30 days): | 464.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.27 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.86 - $3.36 | Next Earning Date: | 11-11-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Acumen Pharmaceuticals Inc. News
ABOS Breaking Stock News: Dive into ABOS Ticker-Specific Updates for Smart Investing
Fortune
5 months ago
Philanthropy CEO: Silicon Valley entrepreneurs who think they can cure poverty are a red flag
Fortune
5 months ago
Acumen CEO: Entrepreneurs who think they can cure poverty with the Silicon Valley model are a red flag
GuruFocus.com
5 months ago
Acumen Pharmaceuticals Inc (ABOS) Q1 2025 Earnings Call Highlights: Strategic Advancements Amid ...
Thomson Reuters StreetEvents
5 months ago
Q1 2025 Acumen Pharmaceuticals Inc Earnings Call
GlobeNewswire
6 months ago
Acumen Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
6 months ago
Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference
GlobeNewswire
6 months ago
Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
GlobeNewswire
7 months ago
Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting
Compare ABOS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ABOS Acumen Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.